A recent study finds that walking between 6,000 and 9,000 steps daily is linked to a dramatically lower risk of cardiovascular disease for older adults. Each additional 1,000 steps taken daily, especially for people who currently walk less than 3,000 steps a day, marks a substantial reduction in cardiovascular risk.
The study analyzed data from over 20,000 people in the United States and 42 other countries.
Experts say that it is not difficult to track one’s daily step counts even without a fitness tracking device.
A new study suggests that people over 60 may significantly reduce their risk of cardiovascular disease by walking between 6,000 and 9,000 steps per day.
Compared to people who walked 2,000 steps per day, researchers found that individuals walking between 6,000 and 9,000 steps daily had a reduced risk of cardiovascular disease, including heart attacks and strokes, by 40% to 50%.
This study focuses on cardiovascular disease (CVD) risk. It is a companion to an earlier study from Vanderbilt University Medical Center in Nashville, TN. The earlier study demonstrated that walking 8,200 steps a day can lower the risk of a wide range of chronic health issues. The new study reports the findings of a meta-analysis of eight prospective studies using health data from 20,152 individuals in the United States and 42 other countries. Their average age was 63.2 years, plus or minus 12.4 years, with 52% being women. The study appears in the journal CirculationTrusted Source. Walk more to lower CVD risk Medical News Today spoke with Dr. Amanda Paluch, a physical activity epidemiologist and kinesiologist at the University of Massachusetts Amherst, who leads the Steps for Health Collaborative. Dr. Paluch said people who currently walk between 2,000 and 3,000 steps a day would experience the most significant reduction in CVD risk by walking more. For those already taking 7,000 steps a day, the improvement would be less dramatic, though still significant, Dr. Paluch noted. The study found that for every 1,000 steps added, there was an incremental reduction in CVD risk.
